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Replication of a Glaucoma Candidate Gene on 5q22.1
for Intraocular Pressure in Mongolian Populations:
The GENDISCAN Project
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PURPOSE. Glaucoma is the second most frequent cause of visual
impairment worldwide. Elevated intraocular pressure (IOP)
causes glaucomatous optic nerve damage, especially in the
primary open-angle glaucoma (POAG) subtype. As most previ-
ous studies on IOP genetics were analyses of glaucomatous
families, a study of general pedigrees will provide additional
information on genetic etiology.
METHODS. This work was part of the GENDISCAN study (Gene
Discovery for Complex Traits in Isolated Large Families of
Asians of the Northeast), which recruited families from popu-
lation isolates in Mongolia. IOP (obtained by a noncontact
method), epidemiologic, and clinical information were col-
lected from 1451 healthy individuals of 142 families. From
these individuals, 390 genome-wide short tandem repeat mark-
ers were genotyped. Variance component-based linkage anal-
ysis was applied to pursue candidate loci explaining IOP vari-
ation.
RESULTS. The mean IOP was 13.6 mm Hg in the men and 13.7
mm Hg in the women, inversely associated with aging ( 
0.05; P  0.0001). The heritability of IOP was 0.48. Sugges-
tive linkage evidence was found on the 5q22.1 region (LOD
score, 2.4), which harbors WDR36, a candidate gene for
POAG. In addition, possible linkage evidence was found on
2q37.1, 7p15.3, 17q25.3, and 20p13.
CONCLUSIONS. The findings support evidence that IOP regula-
tion is associated with the 5q22.1 region, along with four other
candidate regions. The present results further indicate that
genetic factors regulating IOP in the general Mongolian popu-
lation are linked to regions harboring POAG genes, suggesting
that common genetic factors influence both normal IOP vari-
ation and POAG occurrence. In addition, the replication of
previous findings concerning POAG regions from the white
and African populations implies that the mutations regulating
IOP levels did not occur recently. (Invest Ophthalmol Vis Sci.
2010;51:1335–1340) DOI:10.1167/iovs.09-3979
Glaucoma is the second most common cause of blindnessworldwide, with a racially variable prevalence rate of 1%
to 3%.1,2 In 2010, glaucoma is predicted to affect 60.5 million
people, with this number predicted to increase to 79.6 million
by 2020.3 The prevalence of primary glaucoma in the Mongo-
lian population seems to be different from that in white pop-
ulations. Primary angle-closure glaucoma (PACG) is more com-
mon (1.4%), and primary open-angle glaucoma (POAG) less
common (0.5%) in the Mongolian population than in white
populations.4,5 For example, The Baltimore Eye Survey found a
POAG prevalence of 1.4% in the examined white population.5
Previous studies of subjects with elevated intraocular pressure
(IOP) have shown a higher prevalence of glaucoma6,7; more-
over, eyes with higher IOP showed more severe glaucomatous
optic nerve damage and visual impairment. Although IOP is not
a necessary condition for glaucoma, it is a major risk factor for
the disease. Therefore, the investigation of genes that influence
IOP may help to elucidate the genetic mechanisms of IOP
regulation as well as the genetic background of glaucoma.
Three genes have been identified in families of patients with
glaucoma: myocilin (1q24.3-q25.2, in a family affected with an
autosomal dominant form of juvenile open-angle glaucoma8),
optineurin (10p15-p14, in a large British family with a classic
form of normal-tension open-angle glaucoma9), and WD40-
repeat 36 (WDR36; 5q21.3-q22.1, in families with adult-onset
POAG10).
The environmental risk factors of IOP are not well under-
stood, although previous studies11,12 support genetic contribu-
tions. Heritabilities of IOP were reported to be 0.35 in the
Erasmus Rucphen Family study,13 0.36 in the Beaver Dam Eye
Study,11 and 0.29 in the Salisbury Eye Evaluation Study.12
Several studies have reported quantitative trait loci (QTLs) that
influence IOP levels. However, in general, QTLs for IOP have
not been proven either by replication or identifying the caus-
ative variant. Duggal et al.14 reported two regions on chromo-
somes 6 and 13 linked to IOP in a middle-aged normal popu-
lation in the United States. Charlesworth et al.15 demonstrated
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that the 10q22 region was linked to maximum IOP in one large
POAG Australian pedigree. Rotimi et al.16 reported 5q and 14q
QTLs in families with type II diabetes in an African population.
Finally, Duggal et al.17 reported 19p as a novel candidate region
controlling IOP in a white population.
The lack of replication among QTLs of IOP may be partly
attributable to the differences in ascertainment strategy (glau-
comatous families or general population) or in the age distri-
bution of participants. Other explanations of the discrepancy
include ethnic differences in the etiology represented by the
difference in glaucoma epidemiology, as well as genetic het-
erogeneity across populations. The phenotypic variability, in-
cluding intraindividual variation and measurement errors and
the complex mechanisms of optic nerve damage, may be other
reasons for the lack of replication.
Since most studies regarding the genetics of glaucoma or
IOP have been performed in non-Asian populations, studies
from Asians, with different glaucoma epidemiology, will
augment existing evidence. There are several reasons for
this. First, the ratio of POAG to angle-closure glaucoma
(ACG) is substantially different between Asian and white
populations.5 Second, the age-related patterns of change in
IOP differ between these populations, displaying negative
age association in East Asian populations18 –21 and positive
age associations in West Asian22,23 and Caucasian24,25 pop-
ulations. In addition, mean IOP levels in Mongolian, Chi-
nese, and Japanese populations are lower than those in
white26,27 populations. These ethnic differences in clinical
and epidemiologic features of IOP suggest roles of both
genetics and environment.
Studies of healthy participants from population isolates in
Asia will not only reduce variations from environments and
genetic heterogeneity, but will provide insight concerning
epidemiologic differences. The GENDISCAN (GENe DIScovery
for Complex traits in isolated large families of Asians of the
Northeast) study is uniquely powerful in this regard. It is one of
the rare studies of Northeast Asians tailored to gene discovery.
Using homogeneous population isolates, using families not
selected according to their health status, and recruiting large
and extended families are several ways to increase the power
of detecting genes that regulating IOP.
MATERIALS AND METHODS
This study was performed as part of the GENDISCAN study designed to
research the genetic backgrounds of several complex traits of the Asian
population. In 2004, 142 large and complex pedigrees composed of
1451 family members were collected in 2004 in Orhongol, Selengae
Province, Mongolia. The pedigree structure was complicated, with
compound generations and numerous full and half-siblings, cousins,
and spouses. Pedigree relationship information was determined by
personnel interviews and confirmed by genotype data. The study
adhered to the tenets of the Declaration of Helsinki. Informed consent
was obtained from all subjects, and each study protocol was approved
by the institutional review board of Seoul National University (approval
number H-0307-105-002).
One trained examiner measured IOP in both eyes by noncontact
tonometry (NCT; model TM800; Kowa, Torrance, CA). The average of
two successive measurements was regarded as the IOP for each eye. In
cases in which the difference between the two consecutive IOP mea-
surements was 3 mm Hg, one more measurement was performed,
and the average of all three measurements was used. A total of 219
individuals 13 years-of-age without reliable IOP measurements and
one individual with a self-reported history of diabetes were excluded.
We collected additional epidemiologic data and clinical information,
including basic demographics; anthropometries such as height,
weight, waist circumference, and systolic/diastolic blood pressure;
clinical tests such as fasting plasma glucose level and blood lipids; and
personal and family histories of disease.
Genotyping was conducted with linkage mapping (Prism Linkage
Mapping Set, ver. 2.5; Applied Bioscience, Inc. [ABI], Foster City, CA)
containing 400 short tandem repeat markers. An additional 80 Marsh-
field microsatellite markers were adopted to make up intermarker gaps
that resulted from genotype errors (markers with an error rate 1%) or
insufficient information (a heterozygote index 0.4). Extensive quality
checks were performed to verify consistency of marker genotyping
and self-reported pedigree relationships. Genetic distances were based
on the public Marshfield sex-averaged genetic map. Pedigree errors
were found and corrected by using PREST.28 Paternity errors were
detected and removed with Simwalk2 software (http://www.genetics.
ucla.edu/software/simwalk/ provided in the public domain by the
Department of Genetics, David Geffen School of Medicine, UCLA, Los
Angeles, CA).29 Lists of original and additional markers are provided in
TABLE 1. Basic Characteristics of the Participants
Characteristic Men Women Total
Study subjects, n* 346 (40.2) 514 (59.8) 860
Age, y† 33.5 (16.5) 34.6 (16.5) 34.1 (16.5)
IOP, mm Hg by age† 13.6 (13.2–14.0) 13.7 (13.3–14.1) 13.7 (13.4–14.0)
13–19 y (n  238) 14.6 (14.2–15.0) 15.8 (15.4–16.2) 15.3 (14.9–15.7)
20–29 y (n  134) 14.6 (14.1–15.1) 14.3 (13.7–14.9) 14.4 (13.8–15.0)
30–39 y (n  185) 14.0 (13.6–14.4) 13.7 (13.3–14.1) 13.8 (13.4–14.2)
40–49 y (n  147) 14.0 (13.4–14.6) 13.2 (12.7–13.7) 13.6 (13.1–14.1)
50–59 y (n  76) 13.7 (13.0–14.4) 13.8 (13.1–14.5) 13.7 (13.0–14.4)
60 y (n  80) 12.3 (11.7–12.9) 12.4 (11.7–13.1) 12.4 (11.7–13.1)
Range (median) 7–24 (13) 7–26 (13) 7–26 (13)
25%–75% 12–16 12–17 12–16
5%–95% 9–19 10–20 10–20
SBP, mm Hg† 121.5 (119.1–23.9) 120.3 (118.1–22.5) 120.8 (119.2–22.4)
DBP, mm Hg† 81.5 (80.2–82.8) 82.3 (81.2–83.8) 82.0 (81.0–83.0)
Fasting plasma glucose† 89.9 (88.4–91.4) 87.0 (85.7–88.3) 88.2 (87.2–89.2)
Total serum cholesterol† 149.2 (145.6–52.8) 153.5 (150.6–56.4) 151.8 (149.5–54.1)
Triglyceride† 72.6 (68.3–76.9) 68.1 (65.2–71.0) 69.9 (67.1–72.1)
Body mass index† 22.6 (22.2–23.0) 23.6 (23.2–24.0) 23.2 (22.9–23.5)
SBP, systolic blood pressure; DBP, diastolic blood pressure.
* Count (%).
† Mean (95% confidence interval).
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Supplementary Table S1, http://www.iovs.org/cgi/content/full/51/3/
1335/DC1.
The mean IOP measurement of the left eye was used in the analysis;
the correlation of IOP between the left and right eyes was 0.86. The
IOP levels were not normally distributed but instead were right
skewed. Z-transformation was used for heritability and linkage analysis.
Basic statistical analyses were performed (SAS ver. 9; SAS Institute,
Cary, NC), and Familial Correlation30 from SAGE (Statistical Analysis of
Genetic Epidemiology, ver. 4.3; http://darwin.cwru.edu/sage/ pro-
vided in the public domain by the Department of Biostatistics and
Epidemiology, Case Western Reserve University, Cleveland, OH) was
used to estimate familial correlations and the asymptotic standard
errors. In addition, heritability was estimated with the Variance Com-
ponent algorithm in SOLAR (Sequential Oligogenic Linkage Analysis
Routines), version 2.1.431 (http://www.vipbg.vcu.edu/software_docs/
solar/doc/00.contents.html). Multipoint linkage analysis was per-
formed with SOLAR, to localize the QTLs that influence IOP. Expected
LOD scores and empiric locus-specific P-values were calculated by
using a 10,000-permutation simulation.32,33 From the results, LOD
scores of 1.9 to 3.3 were taken as evidence suggestive of linkage.34 All
the analyses outlined were adjusted for age, age2, sex, and interactions
between each age term and sex.
RESULTS
The pedigree data used for this linkage study were obtained
from 1451 individuals from 142 families with 1720 parent–
offsprings, 660 siblings, 946 grandparents, 795 avunculars, 548
cousins, and 452 spousal pairs. With the largest pedigree hav-
ing a bit rate of 207, the average pedigree size was 10.2. Table
1 shows a detailed description of the study population and the
distribution of the trait IOP. Approximately 40% of the subjects
were male. The mean age of the men was 33.5 years and that
of the women, 34.5 years. The mean (95% confidence interval)
IOP was 13.7 (13.4–14.0) mm Hg ranging from 7–26 mm Hg
for all individuals, and 13.6 (13.2–14.0) mm Hg for the men and
13.7 (13.3–14.1) mm Hg for the women. As shown in Table 1,
a decreasing tendency of IOP with age was evident in both
sexes. The mean IOP in the 13- to 19-year and 60-year age
groups was 15.3 mm Hg and 12.4 mm Hg, respectively. The
decreasing trend of IOP with age was significant (0.25 by
5-year with P  0.0001.)
Table 2 shows the age- and sex-adjusted familial correlations
of IOP for each relationship. The intraclass correlation be-
tween sibling pairs was the largest. Notably, spousal pairs
showed a correlation of 0.02, indicating that environment
influences, if any, would only marginally contribute to IOP
variation. The higher correlations evident in closer familial
relationship pairs were strongly suggestive of a role of genetic
factors in controlling IOP levels.
The heritability (SE) for IOP was 0.48 (0.06; P  0.0001),
which was compatible with the findings in familial correlation
analyses that indicated the importance of genetic factors. The
multivariate normality assumption was met for models under
analysis (residual kurtosis, 0.21) when we adjusted for age,
age2, sex, and interactions between each age term and sex.
On genome-wide linkage scanning, we found several link-
age regions with empiric P  0.001. The highest multipoint
LOD score of IOP was 2.4, with an empiric P  0.0002, on
5q22.1 with the nearest marker D5S2027; the strongest signal
met the Lander-Kruglyak criterion34 for suggestive linkage re-
sults. The one drop from maximum LOD score region spanned
roughly 26 cM, from 126 to 152 cM. Other candidate regions
were located on chromosome 2 with an LOD score of 1.6
(empiric P  0.0032), chromosome 7 with an LOD score of 1.4
(P  0.0051), chromosome 17 with an LOD score of 1.5 (P 
0.0043), and chromosome 20 with an LOD score of 1.5 (P 
0.0043), having the nearest marker (cytogenetic region) of
D2S260 (2q37.1), D7S493 (7p15.3), D17S784 (17q25.3), and
D20S117 (20p13), respectively. Table 3 shows detailed chro-
mosomal information for these regions, including LOD score
and the empiric P from simulation analyses. Figure 1A is a
graphic display of the multipoint linkage analysis across 22
chromosomes. Figure 1B is a more detailed description of
chromosome 5.
DISCUSSION
To our knowledge, this is the first report on QTLs that influ-
ence IOP levels in an Asian population. In our study, suggestive
linkage evidence was observed on 5q22.1, with an LOD score
of 2.4. Previously, 5q22 was reported as a suggestive linkage
region for IOP in a study of a West African population.16 The
5q22.1 region has also been linked to POAG in several other
populations. GLC1G and WDR36, containing glaucoma-caus-
ing mutations, were identified in the 5q22.1 region.10 Several
variants of WDR36 have been associated with POAG.35,36 In a
recent study, alterations in WDR36 in Japanese patients with
POAG were not associated with normotensive POAG, whereas
one variant of WDR36 was significantly associated with high-
tension POAG.37 Our findings not only replicate those of pre-
vious studies but further suggest the possibility that normal
variation in IOP, elevated IOP, and POAG may be regulated by
common genetic factors. The LOD scores in this study did not
TABLE 2. Age- and Sex-Adjusted Intraclass Correlations between
Family Pairs of IOP Levels
Relationship
Pair Count Correlation 95% CI
Parent–offspring 690 0.23 (0.19 to 0.27)
Sibling 374 0.37 (0.31 to 0.43)
Half-sibling 102 0.01 (0.13 to 0.11)
Grandparent 161 0.02 (0.11 to 0.07)
Avuncular 362 0.24 (0.17 to 0.31)
Half-avuncular 161 0.10 (0.1 to 0.21)
Cousin 214 0.03 (0.06 to 0.12)
Half-cousin 91 0.04 (0.10 to 0.18)
Spouse 140 0.02 (0.06 to 0.10)
Data are for genotyped individuals only.


















5 (133) 0.0004 2.4 125–145 0.39 D5S2027 5q22.1
2 (254) 0.0032 1.6 240–266 0.39 D2S206 2q37.1
7 (35) 0.0051 1.4 17–52 0.36 D7S493 7p15.3
17 (130) 0.0043 1.5 118–139 0.35 D17S784 17q25.3
20 (4) 0.0043 1.5 2–16 0.32 D20S117 20p13
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reach the level of significance proposed by Lander and Krug-
lyak.34 However, recent studies on age-related macular degen-
eration and the association of TCF7L2 and type 2 diabetes38,39
demonstrated that replication with suggestive or possible evi-
dence is more convincing than unreplicated findings with
strong LOD scores.
In addition, we found potential linkage evidence on chro-
mosomes 2, 7, 17, and 20, with LOD scores higher than and or
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIGURE 1. (A) Genome-wide multipoint linkage analysis results for IOP. The regions in chromosomes 2, 7, 5, 17, and 20 showed LOD scores
greater than or 1.5. (B) Multipoint linkage results for chromosome 5. The highest LOD score was 2.4, with an empiric P  0.0002. The location
of the WDR36 gene and the highest peak from our analysis were very close.
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equal to 1.5. The locus on 2q37.1, MYP12, is related to high
myopia40 and is also linked to common myopia.41 This region
should be investigated further, as myopia is one of the risk
factors of elevated IOP42 and glaucoma.43 In 2006, a region on
chromosome 7 (7p15.3) was reported to be related to congen-
ital cataract.44 As 17q25 is one of the loci previously reported
to be responsible for POAG,45 it would be worthwhile to focus
on this region for candidate genes as well, although what we
found in the present work is only less than suggestive linkage
evidence. Moreover, 17q25.3 has been linked to systolic blood
pressure,46 which focuses attention on the relationship be-
tween systolic blood pressure and IOP.12,24,47 We used systolic
blood pressure as a covariate in linkage analysis; however,
adjusting for it did not materially alter the LOD score for this
region. Chromosome 20 also showed a potential linkage in this
study; however, 20p13 has not been linked to IOP or glaucoma
to date.
The heritability of IOP was 0.48, which is higher than that
in other studies.11,12,48 The higher heritability is most likely
due, at least in part, to the lesser variation in other environ-
ments and more genetic heterogeneity underlying IOP levels.
Given the higher frequencies of PACG in Mongolia,4 if the
same population were analyzed for genes influencing glau-
coma risk, the results would have explained the risk of PACG
rather than POAG. Our findings alone cannot exclude or in-
clude the possibility that those who have elevated IOP will
develop higher risk of POAG in the Mongolian population.
However, considering our findings on IOP genes and previous
reports on POAG genes, together with the pathogenesis un-
derlying POAG, it is logical to suggest that there is a common
genetic variation in the 5q region that influences both IOP and
POAG risk. Furthermore, the possibility of a common genetic
variant among the Caucasian, African, and Asian populations
suggests that the genetic variation regulating IOP levels is
ancient and is not selected by the evolutionary process.
In this study, we obtained IOP data by using NCT. Although
NCT readings tend to show slightly higher values than Gold-
mann applanation tonometry,20 good correlations between
NCT and Goldmann readings have been reported pre-
viously.49–51 Thus, NCT is a reasonable substitute for the gold
standard method, especially in large-scale epidemiologic studies.
Our study was a large family-based examination of an iso-
lated Asian population. Population admixture is a critical limi-
tation in many genetic studies and may lead to biased results.52
Collecting related individuals from a genetically homogeneous
population not only decreases subpopulation effects but has
greater statistical power.53
There are several limitations to our study. First, we did not
check central corneal thickness in our subjects. As NCT is
more sensitive to the level of central corneal thickness than
Goldmann tonometry,54 we would have obtained more accu-
rate IOP data if we had adjusted IOP according to central
corneal thickness. Second, the subjects did not undergo thor-
ough ophthalmic examinations. More detailed examinations,
such as slit lamp examination, gonioscopic angle assessment,
optic disc examination, and visual field testing, which were all
unavailable in our survey setting, would have yielded addi-
tional information regarding related types of glaucoma. The
IOP levels used in this study were of cross-sectional measure-
ments that include intraindividual variation as well as measure-
ment errors. However, it is unlikely that the variation in IOP
measurement is associated with genetic predisposition and the
resultant biasing of the results. The intraindividual variation
and errors in measurements partly account for the weaker
linkage evidence in this study.
In conclusion, by primary genome-wide linkage analysis in
a general population in Mongolia, we replicated the genomic
region 5q22.1 containing the WDR36 gene. Region 5q22.1 was
previously reported to be linked to IOP in a West African
glaucomatous pedigree, and WDR36 is a causative gene in
POAG. In addition, we discovered four new candidate loci of
IOP regulation, each of which has been reported to be associ-
ated with IOP or IOP-related traits.
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